S. Fukuzumi, D. K. P. Ng et al.
16.0 Hz, 1H, CH=CH), 7.21 (d, J=8.4 Hz, 2H, ArH), 7.20 (d, J=
16.0 Hz, 1H, CH=CH), 7.10 (d, J=16.0 Hz, 1H, CH=CH), 7.02 (d, J=
8.4 Hz, 2H, ArH), 6.94 (d, J=8.4 Hz, 2H, ArH), 6.60 (s, 1H, pyrrole-
H), 6.57 (s, 1H, pyrrole-H), 4.64 (t, J=1.6 Hz, 2H, Fc-H), 4.44 (t, J=
1.6 Hz, 2H, Fc-H), 4.13–4.21 (m, 9H, Fc-H + CH2), 3.89 (t, J=4.8 Hz,
2H, CH2), 3.74–3.79 (m, 2H, CH2), 3.61–3.73 (m, 6H, CH2), 3.55–3.59
(m, 2H, CH2), 3.39 (s, 3H, OCH3), 2.38 (quintet, J=6.0 Hz, 2H, CH2),
1.50 (s, 3H, CH3), 1.47 ppm (s, 3H, CH3); 13C{1H} NMR: d=159.4,
159.1, 152.9, 151.9, 142.0, 141.0, 137.5, 136.9, 134.9, 133.5, 133.2,
129.7, 129.6, 128.8, 127.6, 117.3, 116.8, 114.9, 114.8, 81.9, 71.8, 70.8,
70.6, 70.5, 69.7, 69.6, 68.1, 67.4, 65.4, 59.0, 32.3, 29.9, 29.6,
14.8 ppm; MS (ESI): isotopic clusters peaking at m/z 929 {100%,
[M+Na]+}, 908 {75%, [M]+}, and 889 {35%, [MÀF]+}; HRMS (ESI):
m/z calcd for C47H50BBrF2FeN2NaO5 [M+Na]+: 929.2206, found
929.2183.
Monostyryl BODIPY 3
A mixture of the phenol-containing BODIPY 1 (0.34 g, 1.0 mmol),
aldehyde
2 (0.27 g, 1.0 mmol), glacial acetic acid (2.0 mL,
34.9 mmol), piperidine (2.4 mL, 24.3 mmol), and a small amount of
Mg(ClO4)2 in toluene (60 mL) was refluxed for 3 h. The water
formed during the reaction was removed azeotropically with
a Dean–Stark apparatus. The mixture was concentrated under re-
duced pressure, then the residue was purified by column chroma-
tography using CH2Cl2/ethyl acetate (10:1 v/v) as the eluent. The
pink colored fraction was collected and rotary evaporated to yield
1
the desired product (0.15 g, 26%). H NMR: d=7.52 (d, J=16.4 Hz,
1H, CH=CH), 7.49 (d, J=8.8 Hz, 2H, ArH), 7.15 (d, J=16.4 Hz, 1H,
CH=CH), 7.07 (d, J=8.8 Hz, 2H, ArH), 6.94 (d, J=8.8 Hz, 2H, ArH),
6.88 (d, J=8.8 Hz, 2H, ArH), 6.55 (s, 1H, pyrrole-H), 6.34 (br s, 1H,
OH), 5.98 (s, 1H, pyrrole-H), 4.15 (t, J=4.8 Hz, 2H, CH2), 3.87 (t, J=
4.8 Hz, 2H, CH2), 3.73–3.78 (m, 2H, CH2), 3.64–3.72 (m, 4H, CH2),
3.54–3.59 (m, 2H, CH2), 3.39 (s, 3H, OCH3), 2.58 (s, 3H, CH3), 1.47 (s,
3H, CH3), 1.45 ppm (s, 3H, CH3); 13C{1H} NMR: d=159.5, 156.7,
154.3, 153.2, 142.7, 142.2, 140.2, 135.9, 133.2, 132.0, 129.6, 129.5,
128.9, 126.8, 120.9, 117.4, 117.0, 116.0, 114.9, 71.8, 70.8, 70.6, 70.5,
69.7, 67.4, 59.0, 14.8, 14.7, 14.5 ppm; MS (ESI): isotopic clusters
peaking at m/z 613 {100%, [M+Na]+}, 590 {17%, [M]+}, and 571
{52%, [MÀF]+}; HRMS (ESI): m/z calcd for C33H37BF2N2NaO5 [M+
Na]+: 613.2656, found 613.2659.
Fc-DSBDP Dyad 7
Potassium carbonate (0.16 g, 1.2 mmol) was added to a mixture of
6 (0.18 g, 0.2 mmol) and 4-hydroxybenzaldehyde (0.07 g, 0.6 mmol)
in DMF (30 mL). The resulting mixture was stirred at 808C for 8 h,
then the solvent was removed under reduced pressure. The resi-
due was then mixed with CH2Cl2 (50 mL) and water (50 mL). The
aqueous layer was separated and extracted with CH2Cl2 (50 mL ꢀ
3). The combined organic fractions was dried over anhydrous
MgSO4, then evaporated to dryness. The residue was subject to
column chromatography using CH2Cl2 as the eluent to give 7 as
Fc-DSBDP Dyad 5
1
a blue solid (0.17 g, 89%). H NMR: d=9.90 (s, 1H, CHO), 7.85 (d,
According to the above procedure, the monostyryl BODIPY 3
(0.59 g, 1.0 mmol) was treated with ferrocenecarboxaldehyde (4)
(0.42 g, 2.0 mmol), glacial acetic acid (2.0 mL, 34.9 mmol), piperi-
dine (2.4 mL, 24.3 mmol), and a small amount of Mg(ClO4)2 in re-
fluxing toluene (60 mL) for 24 h. The crude product was purified
by column chromatography using CH2Cl2/ethyl acetate (2:1 v/v) as
the eluent. The blue-colored fraction was collected and rotary
J=8.8 Hz, 2H, ArH), 7.58 (d, J=16.0 Hz, 1H, CH=CH), 7.56 (d, J=
8.8 Hz, 2H, ArH), 7.32 (d, J=16.0 Hz, 1H, CH=CH), 7.21 (d, J=
8.8 Hz, 2H, ArH), 7.19 (d, J=16.0 Hz, 1H, CH=CH), 7.10 (d, J=
16.0 Hz, 1H, CH=CH), 7.05 (d, J=8.8 Hz, 2H, ArH), 7.02 (d, J=
8.8 Hz, 2H, ArH), 6.94 (d, J=8.8 Hz, 2H, ArH), 6.59 (s, 1H, pyrrole-
H), 6.56 (s, 1H, pyrrole-H), 4.64 (t, J=1.6 Hz, 2H, Fc-H), 4.44 (t, J=
1.6 Hz, 2H, Fc-H), 4.31 (t, J=6.0 Hz, 2H, CH2), 4.23 (t, J=6.0 Hz, 2H,
CH2), 4.15–4.20 (m, 7H, Fc-H + CH2), 3.89 (t, J=4.8 Hz, 2H, CH2),
3.73–3.78 (m, 2H, CH2), 3.65–3.72 (m, 4H, CH2), 3.55–3.59 (m, 2H,
CH2), 3.39 (s, 3H, OCH3), 2.34 (quintet, J=6.0 Hz, 2H, CH2), 1.48 (s,
3H, CH3), 1.46 ppm (s, 3H, CH3); 13C{1H} NMR: d=190.7, 163.8,
159.4, 159.2, 153.0, 151.6, 141.9, 140.9, 137.5, 137.0, 135.0, 133.5,
133.3, 132.0, 130.0, 129.8, 129.7, 128.8, 127.6, 117.4, 117.2, 116.8,
114.9, 114.8, 114.7, 81.9, 71.9, 70.8, 70.6, 70.5, 69.7, 68.1, 67.4, 64.8,
64.2, 59.0, 29.1, 14.8 ppm; MS (ESI): isotopic clusters peaking at m/
z 971 {52%, [M+Na]+} and 948 {100%, [M]+}; HRMS (ESI): m/z
calcd for C54H55BF2FeN2O7 [M]+: 948.3414, found 948.3411.
1
evaporated to yield the desired product (0.25 g, 32%). H NMR: d=
7.58 (d, J=16.0 Hz, 1H, CH=CH), 7.55 (d, J=8.8 Hz, 2H, ArH), 7.32
(d, J=16.0 Hz, 1H, CH=CH), 7.19 (d, J=16.0 Hz, 1H, CH=CH), 7.15
(d, J=8.8 Hz, 2H, ArH), 7.10 (d, J=16.0 Hz, 1H, CH=CH), 6.95 (d,
J=8.4 Hz, 2H, ArH), 6.93 (d, J=8.4 Hz, 2H, ArH), 6.59 (s, 1H, pyr-
role-H), 6.56 (s, 1H, pyrrole-H), 5.36 (s, 1H, OH), 4.64 (t, J=1.8 Hz,
2H, Fc-H), 4.43 (t, J=1.8 Hz, 2H, Fc-H), 4.14–4.20 (m, 7H, CH2 + Fc-
H), 3.89 (t, J=4.8 Hz, 2H, CH2), 3.74–3.79 (m, 2H, CH2), 3.65–3.73
(m, 4H, CH2), 3.54–3.59 (m, 2H, CH2), 3.39 (s, 3H, OCH3), 1.50 (s, 3H,
CH3), 1.47 ppm (s, 3H, CH3); 13C{1H} NMR: d=159.3, 156.6, 152.9,
151.7, 142.0, 141.1, 137.7, 136.9, 135.0, 133.6, 133.4, 129.9, 129.7,
128.9, 127.0, 117.3, 116.8, 115.9, 114.8, 82.0, 71.9, 70.8, 70.6, 70.5,
70.4, 69.7, 68.1, 67.4, 59.0, 14.8 ppm; MS (ESI): an isotopic cluster
peaking at m/z 786 {100%, [M]+}; HRMS (ESI): m/z calcd for
C44H45BF2 FeN2O5 [M]+: 786.2734, found 786.2729.
Fc-DSBDP-C60 Triad 8
Dyad 7 (47 mg, 0.05 mmol) and sarcosine (44 mg, 0.50 mmol) were
added to a solution of C60 (72 mg, 0.10 mmol) in toluene (50 mL).
The mixture was heated under reflux for 12 h. After cooling slowly
to room temperature, the solvent was removed under reduced
pressure. The residue was purified by column chromatography
using toluene, and then toluene/ethyl acetate (10:1 v/v) as the elu-
ents. The product was obtained as a dark purple solid (43 mg,
51%). 1H NMR: d=7.73 (br s, 2H, ArH), 7.58 (d, J=16.0 Hz, 1H,
CH=CH), 7.56 (d, J=8.8 Hz, 2H, ArH), 7.31 (d, J=16.0 Hz, 1H, CH=
CH), 7.19 (d, J=16.0 Hz, 1H, CH=CH), 7.18 (d, J=8.8 Hz, 2H, ArH),
7.09 (d, J=16.0 Hz, 1H, CH=CH), 6.97–7.03 (m, 4H, ArH), 6.94 (d,
J=8.8 Hz, 2H, ArH), 6.58 (s, 1H, pyrrole-H), 6.55 (s, 1H, pyrrole-H),
4.98 (d, J=9.2 Hz, 1H, pyrrolidine-H), 4.89 (s, 1H, pyrrolidine-H),
4.63 (t, J=1.8 Hz, 2H, Fc-H), 4.44 (t, J=1.8 Hz, 2H, Fc-H), 4.16–4.27
(m, 12H, Fc-H, pyrrolidine-H, and CH2), 3.89 (t, J=4.8 Hz, 2H, CH2),
3.74–3.78 (m, 2H, CH2), 3.66–3.72 (m, 4H, CH2), 3.55–3.58 (m, 2H,
Fc-DSBDP Dyad 6
Potassium carbonate (0.55 g, 4.0 mmol) was added to a mixture of
5 (0.15 g, 0.2 mmol) and 1,3-dibromopropane (0.81 g, 4.0 mmol) in
DMF (15 mL). The resulting mixture was stirred at room tempera-
ture overnight. The volatiles were then evaporated under reduced
pressure and the residue was mixed with CH2Cl2 (40 mL) and water
(40 mL). The aqueous layer was separated and extracted with
CH2Cl2 (40 mL x 3). The combined organic fractions were dried
over anhydrous MgSO4, then evaporated to dryness. The residue
was purified by column chromatography using CH2Cl2 as the
1
eluent to give 6 as a blue solid (0.17 g, 94%). H NMR: d=7.59 (d,
J=16.0 Hz, 1H, CH=CH), 7.56 (d, J=8.4 Hz, 2H, ArH), 7.32 (d, J=
&6
&
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemPhysChem 0000, 00, 1 – 8
ÝÝ
These are not the final page numbers!